Clinical Trial Update: Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis

View source ↗

Summary

This entry describes a pharmacokinetics study of golimumab in adults with moderate to severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Ulcerative Colitis | Status: UNKNOWN